Please use this identifier to cite or link to this item: 10.2478/prolas-2022-0102
Title: Characteristics of the dual nature of the P27 protein in oral leukoplakias and cancer
Authors: Dzudzilo, Madara
Čēma, Ingrīda
Kleina, Regīna
Svirskis, Šimons
Selga, Guntars
Rīga Stradiņš University
Department of Pathology
Institute of Microbiology and Virology
Keywords: oral precancers;oral carcinoma;CDKN1B;tumour suppressor gene p27;oncogene p27;3.2 Clinical medicine;1.1. Scientific article indexed in Web of Science and/or Scopus database;SDG 3 - Good Health and Well-being
Issue Date: 2022
Citation: Dzudzilo , M , Čēma , I , Kleina , R , Svirskis , Š & Selga , G 2022 , ' Characteristics of the dual nature of the P27 protein in oral leukoplakias and cancer ' , Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. , vol. 76 , no. 5/6 , pp. 665-673 . https://doi.org/10.2478/prolas-2022-0102
Abstract: Dysregulation of the cell cycle is an important factor in a potentially malignant oral disorder. There have not been many studies on the role of the cell cycle regulator p27 in oral non-homogenous leukoplakia. The aim of our study was to characterise the p27 protein in homogenous and non-homogenous oral leukoplakias (OL), in comparison with healthy mucosa and squamous cell carcinoma tissues. The current study included 25 patients with OL, 15 cases with oral squamous cell carcinoma, and 15 samples of healthy oral mucosa, both as comparison groups. Immunohistochemical p27 antigen expression was determined by a standard EnView imaging system. The expression level of p27 in nodular and verrucous leukoplakia was lower than in homogenous OL but higher than in erythroleukoplakia. There was a statistically significant difference (p < 0.05) between the expression of p27 in healthy mucosa and homogenous OL. There was a significantly lower amount of p27 positive cells in oral cancer than in OL (p < 0.0001); however, its intracytoplasmic presence was diagnosed. Our study proved the instability of p27 protein and its dual nature in non-homogenous OL and OSCC, and therefore, it can be used as a predictive marker for the clinical course of these conditions.
Description: Publisher Copyright: © 2022 Madara Dzudzilo et al., published by Sciendo.
DOI: 10.2478/prolas-2022-0102
ISSN: 2255-890X
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:
File SizeFormat 
Characteristics_of_the_dual_nature.pdf2.28 MBAdobe PDFView/Openopen_acces_unlocked


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.